Found 4 hits for monomerid = 204090 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204090
(US9539260, F7 | US9763952, Example F7)Show SMILES COc1ncc(cc1C(F)F)N1CCOc2cnc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r| Show InChI InChI=1S/C24H28F2N4O6S/c1-34-23-18(22(25)26)10-16(12-28-23)30-6-7-35-20-13-27-21(11-19(20)30)36-17-2-5-29(14-17)24(31)15-3-8-37(32,33)9-4-15/h10-13,15,17,22H,2-9,14H2,1H3/t17-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204090
(US9539260, F7 | US9763952, Example F7)Show SMILES COc1ncc(cc1C(F)F)N1CCOc2cnc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r| Show InChI InChI=1S/C24H28F2N4O6S/c1-34-23-18(22(25)26)10-16(12-28-23)30-6-7-35-20-13-27-21(11-19(20)30)36-17-2-5-29(14-17)24(31)15-3-8-37(32,33)9-4-15/h10-13,15,17,22H,2-9,14H2,1H3/t17-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204090
(US9539260, F7 | US9763952, Example F7)Show SMILES COc1ncc(cc1C(F)F)N1CCOc2cnc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r| Show InChI InChI=1S/C24H28F2N4O6S/c1-34-23-18(22(25)26)10-16(12-28-23)30-6-7-35-20-13-27-21(11-19(20)30)36-17-2-5-29(14-17)24(31)15-3-8-37(32,33)9-4-15/h10-13,15,17,22H,2-9,14H2,1H3/t17-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204090
(US9539260, F7 | US9763952, Example F7)Show SMILES COc1ncc(cc1C(F)F)N1CCOc2cnc(O[C@H]3CCN(C3)C(=O)C3CCS(=O)(=O)CC3)cc12 |r| Show InChI InChI=1S/C24H28F2N4O6S/c1-34-23-18(22(25)26)10-16(12-28-23)30-6-7-35-20-13-27-21(11-19(20)30)36-17-2-5-29(14-17)24(31)15-3-8-37(32,33)9-4-15/h10-13,15,17,22H,2-9,14H2,1H3/t17-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |